Antigenic and structural insights into Langya henipavirus attachment glycoprotein. [PDF]
Li Y +9 more
europepmc +1 more source
The Nipah virus threat in India: Epidemiological trends, risk drivers, and lessons for pandemic preparedness. [PDF]
Apoorva, Singh SK.
europepmc +1 more source
Hendra virus genotypes 1 and 2 differ in V protein-mediated immune evasion. [PDF]
Tripp MN +6 more
europepmc +1 more source
A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challenge. [PDF]
Pigeaud DD +10 more
europepmc +1 more source
Persistent T Cell Immunity Following Nipah Virus Infection: Evidence From Malaysian Survivors. [PDF]
Ibrahim PAS +7 more
europepmc +1 more source
A highly potent, stable, and safe dePEGylated lipopeptide against Nipah virus and related henipaviruses. [PDF]
Wang Y +15 more
europepmc +1 more source
A recombinant Cedar virus preclinical model that recapitulates neurological features of henipavirus disease. [PDF]
Huaman C +11 more
europepmc +1 more source
Nipah virus preparedness in a One Health framework: Implications for Europe. [PDF]
Grzybek M, Mundt B, Kant R, Bogacka A.
europepmc +1 more source
Bifurcations and optimal control in Nipah virus epidemiology. [PDF]
Haque Z +4 more
europepmc +1 more source

